Analyte testing method and system

Information

  • Patent Grant
  • 9626480
  • Patent Number
    9,626,480
  • Date Filed
    Friday, November 21, 2014
    10 years ago
  • Date Issued
    Tuesday, April 18, 2017
    7 years ago
Abstract
Various systems and methods of operating an analyte measurement device is provided. The device has a display, user interface, processor, memory and user interface buttons. In one example, one of the methods can be achieved by measuring an analyte with the analyte measurement device; displaying a value representative of the analyte; prompting a user to activate a test reminder; and activating the test reminder to remind a user to conduct a test measurement at a different time. Other methods and systems are also described and illustrated.
Description
BACKGROUND

Glucose monitoring is a fact of everyday life for diabetic individuals. The accuracy of such monitoring can significantly affect the health and ultimately the quality of life of the person with diabetes. Generally, a diabetic patient measures blood glucose levels several times a day to monitor and control blood sugar levels. Failure to test blood glucose levels accurately and on a regular basis can result in serious diabetes-related complications, including cardiovascular disease, kidney disease, nerve damage and blindness. There are a number of electronic devices currently available which enable an individual to test the glucose level in a small sample of blood. One such glucose meter is the OneTouch® Profile™ glucose meter, a product which is manufactured by Lifescan Inc.


In addition to glucose monitoring, diabetic individuals often have to maintain tight control over their lifestyle, so that they are not adversely affected by, for example, irregular food consumption or exercise. In addition, a physician dealing with a particular diabetic individual requires detailed information on the lifestyle of the individual to provide effective treatment or modification of treatment for controlling diabetes. Currently, one of the ways of monitoring the lifestyle of an individual with diabetes has been for the individual to keep a paper logbook of their lifestyle, and to test their blood glucose on a regular basis, particularly before meals, after meals, and when fasting. Another way is for an individual to simply rely on remembering facts about their lifestyle and when they test, and then relay these details to their physician on each visit.


The aforementioned methods of recording lifestyle information are inherently difficult, time consuming, and possibly inaccurate. It's easy to forget to test, and paper logbooks are not always carried by an individual and may not be accurately completed when required. Paper logbooks are small and it is difficult to enter detailed information requiring detailed descriptors of lifestyle events. Furthermore, an individual may often forget key facts about their lifestyle when questioned by a physician who has to manually review and interpret information from a hand-written notebook. There is no analysis provided by the paper logbook to distil or separate the component information, and there is no way for a paper logbook to proactively remind a user to test. Also, there are no graphical reductions or summary of the information. Entry of data into a secondary data storage system, such as a database or other electronic system, requires a laborious transcription of information, including lifestyle data, into this secondary data storage. Difficulty of data recordation encourages retrospective entry of pertinent information that results in inaccurate and incomplete records.


Moreover, a diabetic individual often has to keep a plurality of devices on their person for diagnosis and treatment, for example both glucose level monitoring equipment and medication. Hence, having to carry paper records of their lifestyle and a log of when they test is an added unwanted burden, and entry of data therein is very time consuming.


There currently exist a number of portable electronic devices that can measure glucose levels in an individual and store the levels for recalling or uploading to another computer for analysis. One such device is the Accu-Check™ Complete™ System from Roche Diagnostics, which provides limited functionality for storing lifestyle data. However, the Accu-Check™ Complete™ System only permits a limited selection of lifestyle variables to be stored in a meter. There is a no intelligent feedback from values previously entered into the meter and the user interface is unintuitive for an infrequent user of the meter. In addition, there is no convenient way to remind the user when to test, and to assure that tests are being conducted at appropriate times.


SUMMARY OF THE DISCLOSURE

Applicants have recognized a need for an electronic device that reminds the user when to test and that provides assurance that tests are being conducted and recorded at appropriate times. Such device must be intuitive and easier to use, thereby encouraging an individual to test at appropriate times. Appropriate times should be taken to mean times that are particularly relevant to management of diabetes, and which might affect or represent an individual's physical condition. Examples of appropriate times are before and after food consumption, before and after physical exertion (e.g. exercise), before and after medication intake, and after fasting.


In view of the foregoing and in accordance with one aspect, there is provided a method of operating an analyte measurement device having a display, user interface, processor, memory and user interface buttons, the method can be achieved by measuring an analyte with the analyte measurement device; displaying a value representative of the analyte; prompting a user to activate a test reminder; and activating the test reminder to remind a user to conduct a test measurement at a different time.


In an embodiment, the prompting includes repetitively flashing on the display an icon representative of one of the user interface buttons to prompt a selection of such user interface button.


In an embodiment, the prompting includes illuminating one of the user interface buttons to prompt a selection of such user interface button.


In an embodiment, the method further includes disabling all of the user interface buttons except for one of the user interface buttons.


In an embodiment, the user interface buttons include an up button, a down button, an enter button, and a test reminder button.


In an embodiment, the test reminder includes a before meal test reminder or an after meal test reminder.


In an embodiment, the test reminder includes an after meal test reminder.


In an embodiment, the prompting includes always prompting a user whenever a measuring step has been completed.


In an embodiment, the prompting includes prompting a user whenever a measuring step was taken before a meal.


In an embodiment, the activating includes storing in memory the date and time to display the test reminder.


In an embodiment, the analyte measurement device includes a glucose meter.


In an embodiment, the measuring includes inserting a test strip into a strip port provided by the measurement device; and depositing a blood sample on a testing portion of the test strip without entering a calibration parameter for the test strip.


In an embodiment, the measuring includes inserting a test strip into a strip port provided by the measurement device; inputting a calibration parameter for the test strip via the user interface buttons of the device; and depositing a blood sample on a testing portion of the test strip.


In an embodiment, the inserting includes turning on the measurement device when the strip is fully inserted into the strip port.


In an embodiment, the plurality of menus to be displayed is selected.


In an embodiment, the plurality of menus includes at least one time for the test reminder.


In view of the foregoing and in accordance with another aspect, there is provided a method of operating an analyte measurement device having a display, user interface, processor, memory and user interface buttons, the method can be achieved by pressing one of the user interface buttons to turn the analyte measurement device on, prompting a user to confirm selection of a test reminder, and pressing one of the user interface buttons to confirm selection of a test reminder.


In an embodiment, the prompting includes repetitively flashing on the display an icon representative of one of the user interface buttons to prompt selection of such user interface button.


In an embodiment, the prompting includes illuminating one of the user interface buttons to prompt a selection of such user interface button.


In an embodiment, the method further includes disabling all of the user interface buttons except for one of the user interface buttons.


In an embodiment, the user interface buttons include an up button, a down button, an enter button, and a test reminder button.


In an embodiment, the test reminder includes a before meal test reminder or an after meal test reminder.


In an embodiment, the test reminder includes an after meal test reminder.


In an embodiment, the confirming includes storing in memory the date and time to display the test reminder.


In an embodiment, the analyte measurement device includes a glucose meter.


In an embodiment, the plurality of menus to be displayed is selected.


In an embodiment, the plurality of menus includes at least one time for the test reminder.


In view of the foregoing and in accordance with another aspect, there is provided an analyte measurement device comprising a housing having: a strip port coupled to an analyte measurement unit; a processor coupled to the analyte measurement unit, a memory, user interface input, and a display driver; a display unit coupled to the display driver; and a plurality of user interface buttons including a test reminder button so that upon activation of the test reminder button, a time and date can be stored in the memory to remind the user to conduct a measurement.


These and other embodiments, features and advantages will become apparent to those skilled in the art when taken with reference to the following more detailed description of the invention in conjunction with the accompanying drawings that are first briefly described.





BRIEF DESCRIPTION OF THE FIGURES

The accompanying drawings, which are incorporated herein and constitute part of this specification, illustrate presently preferred embodiments of the invention, and, together with the general description given above and the detailed description given below, serve to explain features of the invention (wherein like numerals represent like elements), of which:



FIG. 1 is an exemplary plan view of an analyte measurement device, according to an embodiment.



FIG. 2 is an exemplary block diagram illustrating the principal internal components of an analyte measurement device, according to an embodiment.



FIG. 3 is an exemplary flow chart illustrating a method of operating an analyte measurement device, according to an embodiment.



FIG. 4 is an exemplary flow chart illustrating a method of operating an analyte measurement device when only a single user interface button on the analyte measurement device is active, according to an embodiment.



FIG. 5 is an exemplary flow chart illustrating a method of operating an analyte measurement device where a user is prompted to activate a test reminder whenever a previous measuring process was taken before a meal, according to an embodiment.



FIG. 6 is an exemplary flow chart illustrating a method of operating an analyte measurement device where the date and time to display a test reminder are stored in the memory of an analyte measurement device, according to an embodiment.



FIG. 7 is an exemplary flow chart illustrating a method of operating an analyte measurement device after inserting a test strip into a strip port in the analyte measurement device, according to an embodiment.



FIG. 8 is an exemplary flow chart illustrating a method of operating an analyte measurement device after inserting a test strip into a strip port in the analyte measurement device and either entering or confirming calibration parameters of the test strip, according to an embodiment.



FIG. 9 is an exemplary flow chart illustrating a method of operating an analyte measurement device after inserting a test strip into a strip port in the analyte measurement device thereby turning the analyte measurement device on, according to an embodiment.



FIG. 10 is an exemplary flow chart illustrating a method of operating an analyte measurement device where the analyte measurement device is turned on by pressing a user interface button, a user is prompted to confirm selection of a test reminder, and a user interface button is pressed to confirm selection of a test reminder, according to an embodiment.



FIG. 11 is an exemplary flow chart illustrating a method of operating an analyte measurement device when only a single user interface button on the analyte measurement device is active, according to an embodiment.



FIG. 12 is an exemplary flow chart illustrating a method of operating an analyte measurement device where the date and time to display a test reminder are stored in the memory of an analyte measurement device, according to an embodiment.



FIG. 13 is an exemplary flow chart illustrating a method of operating an analyte measurement device and actions taken by the analyte measurement device, according to an embodiment.





DETAILED DESCRIPTION OF THE FIGURES

The following detailed description should be read with reference to the drawings, in which like elements in different drawings are identically numbered. The drawings, which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of the invention. The detailed description illustrates by way of example, not by way of limitation, the principles of the invention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.



FIG. 1 illustrates an analyte measurement device 100, for testing glucose levels in the blood of an individual. Analyte measurement device 100 may include user interface buttons (106, 108, 110, 114) for entry of data, navigation of menus, and execution of commands. Data can include values representative of analyte concentration, and/or information, which are related to the everyday lifestyle of an individual. Information, which is related to the everyday lifestyle, can include food intake, medication use, the occurrence of health check-ups and general health condition and exercise levels of an individual. Analyte measurement device 100 also may include display 104. Display 104 can be used to report measured glucose levels, and to facilitate entry of lifestyle related information.


Analyte measurement device 100 may include first user interface button 106, second user interface button 108, third user interface button 110, and test reminder button 114. User interface buttons 106, 108, and 110 facilitate entry and analysis of data stored in the testing device, enabling a user to navigate through the user interface displayed on display 104. Test reminder button 114 allows test reminders to be set. User interface buttons 106, 108, and 110 include first marking 107, second marking 109, and third marking 111, which help in correlating user interface buttons to characters on display 104. Test reminder button 114 can include markings as well, helping to correlate test reminder button 114 with to characters on display 104.


Analyte measurement device 100 can be turned on by inserting a test strip 10 into strip port 112, by pressing and briefly holding first user interface button 106, or when data traffic is detected across optional data port 113. Analyte measurement device 100 can be switched off by removing the test strip 10, pressing and briefly holding first user interface button 106, navigating to and selecting a meter off option from a main menu screen, or by not pressing any buttons for a predetermined time. Display 104 can optionally include a backlight. The test strip port 112 may include its own light source or the port 112 may share a common light source with the backlight for the display 104.


Data port 113 is optional, and accepts a suitable connector attached to a connecting lead, thereby allowing analyte measurement device 100 to be linked to an external device such as a personal computer. Data port 113 can be any port that allows for transmission of data (serial or parallel) such as, for example, serial or parallel port in wired or wireless form. A personal computer, running appropriate software, allows entry and modification of set-up information (e.g. the current time, date, and language), and can perform analysis of data collected by analyte measurement device 100. In addition, the personal computer may be able to perform advanced analysis functions, and/or transmit data to other computers (i.e. over the internet) for improved diagnosis and treatment. Connecting analyte measurement device 100 with a local or remote computer facilitates improved treatment by health care providers.


Referring to FIG. 2, an exemplary internal layout of analyte measurement device 100 is shown. Analyte measurement device 100 may include a processor 200, which in some embodiments described and illustrated herein is a 32-bit RISC microcontroller. The processor can be bi-directionally connected via I/O ports 214 to memory 202, which in some embodiments described and illustrated herein is an EEPROM. Also connected to processor 200 via I/O ports 214 are the data port 113, the user interface buttons 106, 108, 110, and 114, and a display driver 236. Data port 113 can be connected to processor 200, thereby enabling transfer of data between memory 202 and an external device, such as a personal computer. User interface buttons 106, 108, 110, and 114 are directly connected to processor 200. Processor 200 controls display 104 via display driver 236.


In one embodiment, analyte measurement device 100 may include an Application Specific Integrated Circuit (ASIC) 204, providing electronic circuitry used in measurements of glucose level in blood that has been applied to a test strip 10 inserted into strip port 112. Analog voltages can pass to and from ASIC 204 by way of analog interface 205. Analog signals from analog interface 205 can be converted to digital signals by A/D converter 216. Processor 200 further may include core 208, ROM 210 (containing computer code), RAM 212, and clock 218. In one embodiment, the processor 200 is configured (or programmed) to disable all of the user interface buttons except for a single button upon a display of an analyte value by the display unit such as, for example, during a time period after an analyte measurement. In an alternative embodiment, the processor 200 is configured (or programmed) to ignore any input from all of the user interface buttons except for a single button upon a display of an analyte value by the display unit.



FIG. 3 is an exemplary flow chart illustrating a method of operating an analyte measurement device, according to an embodiment described and illustrated herein. Method 300 may include processes 302, 304, 306, and 308. In process 302, an analyte-measuring device measures an analyte. In process 304, the analyte measuring device displays a value representative of the analyte. In process 306, the analyte measuring device prompts the user to activate a test reminder. In process 308, the user activates a test reminder to remind a user to conduct a test measurement at a different time. In any embodiments described and illustrated herein, the analyte measurement device may include a display, a user interface, a processor, a memory and user interface buttons. Prompting may include repetitively flashing on the display an icon representative of one of the user interface buttons to prompt selection of such user interface button. Alternatively, prompting may include illuminating at least one of the user interface buttons to prompt selection of at least one user interface button. It is noted that the reminder is not limited to before meal or after meal but can be utilized any specific time selected by the user, patient or physician.



FIG. 4 is an exemplary flow chart illustrating a method of operating an analyte measurement device when only a single user interface button on the analyte measurement device is active, according to an embodiment described and illustrated herein. Method 400 may include processes 402, 404, 406, 408, and 410. In process 402, an analyte-measuring device measures an analyte. In process 404, the analyte measuring device displays a value representative of the analyte. In process 406, the analyte measuring device prompts the user to activate a test reminder. In process 408, the analyte measuring device deactivates all but a single user interface button. In process 410, the user activates the test reminder to remind the user to conduct a test measurement at a different time. User interface buttons may include an “up” button, a “down” button, an “enter” or “OK” button, and a test reminder button. In any embodiments described and illustrated herein, the test reminder can include a before meal test reminder or an after meal test reminder. Alternatively, the test reminder can be an after meal test reminder.



FIG. 5 is an exemplary flow chart illustrating a method of operating an analyte measurement device where a user is prompted to activate a test reminder whenever a previous measuring process was taken before a meal, according to an embodiment described and illustrated herein. Method 500 may include processes 502, 504, 506, and 508. In process 502, an analyte-measuring device measures an analyte. In process 504, the analyte measuring device displays a value representative of the analyte. In process 506, the analyte measuring device prompts the user to activate a test reminder whenever a previous measuring process was taken before a meal. In process 508, the user activates a test reminder to remind the user to conduct a test measurement at a different time. In any embodiments described and illustrated herein, the analyte measuring device may prompt the user to activate a test reminder whenever a measuring process has been completed.



FIG. 6 is an exemplary flow chart illustrating a method of operating an analyte measurement device where the date and time to display a test reminder are stored in the memory of an analyte measurement device, according to an embodiment described and illustrated herein. Method 600 may include processes 602, 604, 606, and 608. In process 602, an analyte-measuring device measures an analyte. In process 604, the analyte measuring device displays a value representative of the analyte. In process 606, the analyte measuring device prompts the user to activate a test reminder. In process 608, the user activates a test reminder to remind the user to conduct a test measurement at a different time by storing in the memory of the analyte measurement device the date and time to display the test reminder. In any embodiments described and illustrated herein, the analyte measuring device may include a glucose meter.



FIG. 7 is an exemplary flow chart illustrating a method of operating an analyte measurement device after inserting a test strip 10 into a strip port 112 in the analyte measurement device, according to an embodiment described and illustrated herein. Method 700 may include processes 702, 704, 706, 708, and 710. In process 702, a test strip 10 is inserted into a strip port in an analyte measurement device. In process 704, blood is applied to a test portion (the portion distal from the strip port 112) of the test strip 10 without entering or confirming calibration parameters of the test strip 10. In process 706, the analyte measuring device displays a value representative of the analyte. In process 708, the analyte measuring device prompts the user to activate a test reminder. In process 710, the user activates a test reminder to remind the user to conduct a test measurement at a different time. In any embodiments described and illustrated herein, measuring may include: inserting a test strip 10 into a strip port in the analyte measurement device, then depositing a sample of blood on a testing portion of the test strip 10 without entering a calibration parameter for the test strip 10.



FIG. 8 is an exemplary flow chart illustrating a method of operating an analyte measurement device after inserting a test strip 10 into a strip port in the analyte measurement device and either entering or confirming calibration parameters of the test strip 10, according to an embodiment described and illustrated herein. Method 800 may include processes 802, 804, 806, 808, and 810. In process 802, a test strip 10 is inserted into a strip port in an analyte measurement device. In process 804, blood is applied to a test portion of the test strip 10 after entering or confirming calibration parameters of the test strip 10. In process 806, the analyte measuring device displays a value representative of the analyte. In process 808, the analyte measuring device prompts the user to activate a test reminder. In process 810, the user activates a test reminder to remind the user to conduct a test measurement at a different time. In any embodiments described and illustrated herein, the measuring may include: inserting a test strip 10 into a strip port in the measurement device; inputting a calibration parameter for the test strip 10 via the user interface buttons of the device; and depositing a blood sample on a testing portion of the test strip 10.



FIG. 9 is an exemplary flow chart illustrating a method of operating an analyte measurement device after inserting a test strip 10 into a strip port in the analyte measurement device thereby turning the analyte measurement device on. Method 900 may include processes 902, 904, 906, 908, and 910. In process 902, a test strip 10 is inserted into a strip port in an analyte measurement device, thereby turning it on. In process 904, blood is applied to a test portion of the test strip 10 without entering or confirming calibration parameters of the test strip 10. In process 906, the analyte measuring device displays a value representative of the analyte. In process 908, the analyte measuring device prompts the user to activate a test reminder. In process 910, the user activates a test reminder to remind the user to conduct a test measurement at a different time. In any embodiments described and illustrated herein, inserting may include turning on the measurement device when the strip is fully inserted into the strip port. Alternatively, a plurality of menus may be displayed. In a further embodiment, one of a plurality of menus may include at least one amount of elapsed time for the test reminder.



FIG. 10 is an exemplary flow chart illustrating a method of operating an analyte measurement device where the analyte measurement device is turned on by pressing a user interface button, a user is prompted to confirm selection of a test reminder, and a user interface button is pressed to confirm selection of a test reminder. Method 1000 may include processes 1002, 1004, and 1006. In process 1002, the user presses a user interface button to turn the analyte measurement device on. In process 1004, the analyte measuring device prompts the user to confirm selection of a test reminder. In process 1006, the user presses a user interface button to confirm selection of a test reminder. In any embodiments described and illustrated herein, prompting may include repetitively flashing on the display an icon representative of a single user interface button to prompt selection of the single user interface button. Alternatively, prompting may include illuminating at least one of the user interface buttons to prompt selection of at least one user interface button.



FIG. 11 is an exemplary flow chart illustrating a method of operating an analyte measurement device when only a single user interface button on the analyte measurement device is active. Method 1100 may include processes 1102, 1104, 1006, and 1108. In process 1102, the user presses a user interface button to turn the analyte measurement device on. In process 1104, the analyte measuring device prompts the user to confirm selection of a test reminder. In process 1106, all but a single user interface button on the analyte measurement device are deactivated. In process 1108, the user presses the single activated user interface button to confirm selection of a test reminder. In any embodiments described and illustrated herein, the user interface buttons may include an up button, a down button, an enter button, and a test reminder button. Alternatively, the test reminder may include a before meal test reminder or an after meal test reminder. In a further embodiment, the test reminder may include an after meal test reminder.



FIG. 12 is an exemplary flow chart illustrating a method of operating an analyte measurement device where the date and time to display a test reminder are stored in the memory of an analyte measurement device. Method 1200 may include processes 1202, 1204, and 1206. In process 1202, the user presses a user interface button to turn the analyte measurement device on. In process 1204, the analyte measuring device prompts the user to confirm selection of a test reminder. In process 1206, the user presses the single activated user interface button to confirm selection of a test reminder and to store in the memory of said analyte measurement device the date and time to display said test reminder. The analyte measurement device may include a glucose meter. Alternatively, the method may further include selecting a plurality of menus to be displayed. In a further alternative, the plurality of menus may include at least one elapsed time for the test reminder.



FIG. 13 is an exemplary flow chart illustrating a method of operating an analyte measurement device and actions taken by the analyte measurement device. Method 1300 may include processes 1302, 1304, 1306, 1308, 1310, 1312, 1314, 1316, 1318, and 1320. In process 1302, a user inserts a test strip 10 into a strip port in an analyte measurement device. In process 1304, the analyte measuring device turns on. In process 1306, the analyte-measuring device displays an LCD check screen. In process 1308, the analyte measuring device displays a sample application prompt. In process 1310, the user applies sample to the test strip 10. In process 1312, the analyte measuring device displays a series of countdown screens. In process 1314, the analyte measuring device displays a value representative of the analyte and prompts the user to activate a test reminder. In process 1316, the user optionally activates a test reminder, causing the date and time for the test reminder to be displayed to be stored in the memory of the analyte measurement device. In process 1318, the analyte measurement device optionally displays a test reminder confirmation. In process 1320, the analyte measurement device turns off after a predetermined time, with or without interaction from the user.


In conclusion, the testing device and methods described and illustrated herein significantly reduce obstacles associated with blood glucose testing. Thus the present invention promotes frequent monitoring for diabetic individuals by providing a simple, efficient way of reminding a user to test. By testing in the manner described herein, it is easier for a user to establish proper testing frequency, and provide vital information to health care practitioners.


While the invention has been described in terms of particular variations and illustrative figures, those of ordinary skill in the art will recognize that the invention is not limited to the variations or figures described. In addition, where methods and process described above indicate certain events occurring in certain order, those of ordinary skill in the art will recognize that the ordering of certain process may be modified and that such modifications are in accordance with the variations of the invention. Additionally, certain of the process may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above. Therefore, to the extent there are variations of the invention, which are within the spirit of the disclosure or equivalent to the inventions found in the claims, it is the intent that this patent will cover those variations as well.

Claims
  • 1. A method of operating an analyte measurement device having a display, user interface, processor, memory and user interface buttons, the method comprising: pressing one of the user interface buttons to turn the analyte measurement device on;prompting a user to confirm selection of a test reminder;disabling all of the user interface buttons except a single user interface button enabled for confirming the test reminder; andpressing the enabled user interface button to confirm the selection of the test reminder.
  • 2. The method of claim 1, in which the prompting comprises repetitively flashing on the display an icon representative of one of the user interface buttons to prompt selection of such user interface button.
  • 3. The method of claim 1, in which the prompting comprises illuminating one of the user interface buttons to prompt selection of such user interface button.
  • 4. The method of claim 1, in which the user interface buttons comprise an up button, a down button, an enter button, and a test reminder button.
  • 5. The method of claim 1, in which the test reminder comprises a before meal test reminder or an after meal test reminder.
  • 6. The method of claim 1, in which the test reminder comprises an after meal test reminder.
  • 7. The method of claim 1, in which the confirming comprises storing in memory the date and time to display the test reminder.
  • 8. The method of claim 1, in which the analyte measurement device comprises a glucose meter.
  • 9. The method of claim 1, further comprising selecting a plurality of menus to be displayed.
  • 10. The method of claim 9, in which the plurality of menus comprise at least one time for the test reminder.
  • 11. An analyte measurement device comprising: a housing having: a strip port coupled to an analyte measurement unit;a processor coupled to the analyte measurement unit, a memory, user interface input, and a display driver;a display unit coupled to the display driver; anda plurality of user interface buttons including a test reminder button so that upon activation of the test reminder button, a time and date can be stored in the memory to remind the user to conduct a measurement wherein the processor is programmed to prompt a user to confirm selection of a test reminder and store the date and time in memory and in which the plurality of user interface buttons are disabled by the device with the exception of the test reminder button after the device has been turned on.
PRIORITY

This DIVISIONAL application claims the benefits of priority under 35 USC §§120 and 121 from prior filed U.S. application Ser. No. 12/408,613 filed on Mar. 20, 2009, allowed, which prior filed application (Ser. No. 12/408,613) claims the benefits of priority under 35 USC §119 and/or §120 from prior filed U.S. Provisional Patent Application Ser. No. 61/038,624 filed on Mar. 21, 2008 , in which all prior filed applications are hereby incorporated by reference in their entirety into this application.

US Referenced Citations (293)
Number Name Date Kind
4970172 Kundu Nov 1990 A
5019974 Beckers May 1991 A
5071769 Kundu et al. Dec 1991 A
5077476 Rosenthal Dec 1991 A
5086229 Rosenthal et al. Feb 1992 A
5174959 Kundu et al. Dec 1992 A
5216597 Beckers Jun 1993 A
5307263 Brown Apr 1994 A
5410474 Fox Apr 1995 A
5494562 Maley et al. Feb 1996 A
5529676 Maley et al. Jun 1996 A
5573647 Maley et al. Nov 1996 A
5582698 Flaherty et al. Dec 1996 A
5601694 Maley et al. Feb 1997 A
5616222 Maley et al. Apr 1997 A
5665215 Bussmann et al. Sep 1997 A
5695623 Michel et al. Dec 1997 A
5707502 McCaffrey et al. Jan 1998 A
5708247 McAleer et al. Jan 1998 A
5711868 Maley et al. Jan 1998 A
5770028 Maley et al. Jun 1998 A
5899855 Brown May 1999 A
5951836 McAleer et al. Sep 1999 A
5997475 Bortz Dec 1999 A
6033866 Guo et al. Mar 2000 A
6040195 Carroll et al. Mar 2000 A
6060327 Keen May 2000 A
6136610 Polito et al. Oct 2000 A
6168563 Brown Jan 2001 B1
6241862 McAleer et al. Jun 2001 B1
6246966 Perry Jun 2001 B1
6284550 Carroll et al. Sep 2001 B1
6326215 Keen Dec 2001 B1
D456083 Clark et al. Apr 2002 S
D456910 Clark et al. May 2002 S
6461331 Van Antwerp Oct 2002 B1
6475372 Ohara et al. Nov 2002 B1
D469107 Miller et al. Jan 2003 S
6513532 Mault et al. Feb 2003 B2
6514460 Fendrock Feb 2003 B1
6562625 Modzelewski et al. May 2003 B2
6604050 Trippel et al. Aug 2003 B2
6633772 Ford et al. Oct 2003 B2
6635014 Starkweather et al. Oct 2003 B2
6645368 Beaty et al. Nov 2003 B1
6656114 Poulsen et al. Dec 2003 B1
6685651 Anker et al. Feb 2004 B2
6699667 Keen Mar 2004 B2
6716577 Yu et al. Apr 2004 B1
6726818 Cui et al. Apr 2004 B2
6733655 Davies et al. May 2004 B1
6736957 Forrow et al. May 2004 B1
6743635 Neel et al. Jun 2004 B2
6744350 Blomquist Jun 2004 B2
6767441 Cai et al. Jul 2004 B1
6780645 Hayter et al. Aug 2004 B2
6809507 Morgan et al. Oct 2004 B2
6810290 Lebel et al. Oct 2004 B2
6852104 Blomquist Feb 2005 B2
6872299 Kermani et al. Mar 2005 B2
6890421 Ohara et al. May 2005 B2
6939450 Karinka et al. Sep 2005 B2
6942769 Cheng et al. Sep 2005 B2
6946299 Neel et al. Sep 2005 B2
6953693 Neel et al. Oct 2005 B2
6959247 Neel et al. Oct 2005 B2
6964871 Bell et al. Nov 2005 B2
6979544 Keen Dec 2005 B2
6991940 Carroll et al. Jan 2006 B2
6997344 Brown et al. Feb 2006 B2
7022072 Fox et al. Apr 2006 B2
7024236 Ford et al. Apr 2006 B2
7037196 Kobayashi et al. May 2006 B2
7039878 Auer et al. May 2006 B2
7049130 Carroll et al. May 2006 B2
7054823 Briegs et al. May 2006 B1
7086277 Tess et al. Aug 2006 B2
7112265 McAleer et al. Sep 2006 B1
7160251 Neel et al. Jan 2007 B2
7163616 Vreeke et al. Jan 2007 B2
7179226 Crothall et al. Feb 2007 B2
7204823 Estes et al. Apr 2007 B2
D542681 Young et al. May 2007 S
7212399 Kee et al. May 2007 B2
7220550 Keen May 2007 B2
7223235 Brown et al. May 2007 B2
7223236 Brown et al. May 2007 B2
D545705 Voege Jul 2007 S
7241265 Cummings et al. Jul 2007 B2
7250105 Davies et al. Jul 2007 B1
7251514 Cho et al. Jul 2007 B2
7256714 Philipp et al Aug 2007 B2
7258666 Brown et al. Aug 2007 B2
7258769 Cui et al. Aug 2007 B2
7264591 Brown et al. Sep 2007 B2
7276146 Wisley Oct 2007 B2
7276147 Wisley Oct 2007 B2
7288174 Cui et al. Oct 2007 B2
7291256 Teodorczyk et al. Nov 2007 B2
7311812 Forrow et al. Dec 2007 B2
7323141 Kirchhevel et al. Jan 2008 B2
7338639 Burke et al. Mar 2008 B2
7399277 Saidara et al. Jul 2008 B2
7611899 Whitson et al. Nov 2009 B2
7695677 Werner et al. Apr 2010 B2
7885146 Parkinson et al. Feb 2011 B2
7906336 Whitson et al. Mar 2011 B2
20010011224 Brown Aug 2001 A1
20010056328 Trippel et al. Dec 2001 A1
20020047867 Mault et al. Apr 2002 A1
20020068157 Wischerhoff Jun 2002 A1
20020109600 Mault et al. Aug 2002 A1
20030021729 Mollet et al. Jan 2003 A1
20030032190 Brown et al. Feb 2003 A1
20030032867 Crothall et al. Feb 2003 A1
20030032868 Graskov et al. Feb 2003 A1
20030055406 Lebel et al. Mar 2003 A1
20030060765 Campbell et al. Mar 2003 A1
20030065308 Lebel et al. Apr 2003 A1
20030111357 Black Jun 2003 A1
20030125612 Fox et al. Jul 2003 A1
20030163088 Blomquist Aug 2003 A1
20030163223 Blomquist Aug 2003 A1
20030203498 Neel et al. Oct 2003 A1
20030208113 Mault et al. Nov 2003 A1
20030211617 Jones Nov 2003 A1
20030212379 Bylund et al. Nov 2003 A1
20040015102 Cummings et al. Jan 2004 A1
20040038411 Hayter et al. Feb 2004 A1
20040039255 Simonsen et al. Feb 2004 A1
20040048394 Kirchhevel Mar 2004 A1
20040057340 Charles-Erickson et al. Mar 2004 A1
20040058433 Yu et al. Mar 2004 A1
20040059201 Ginsberg Mar 2004 A1
20040069793 Brown et al. Apr 2004 A1
20040079653 Karinka et al. Apr 2004 A1
20040094432 Neel et al. May 2004 A1
20040094433 Neel et al. May 2004 A1
20040096991 Zhang May 2004 A1
20040099540 Neel et al. May 2004 A1
20040104131 Neel et al. Jun 2004 A1
20040106855 Brown Jun 2004 A1
20040107116 Brown Jun 2004 A1
20040117207 Brown Jun 2004 A1
20040117208 Brown Jun 2004 A1
20040117209 Brown Jun 2004 A1
20040117210 Brown Jun 2004 A1
20040118704 Wang et al. Jun 2004 A1
20040127774 Moore et al. Jul 2004 A1
20040153585 Kawatahara et al. Aug 2004 A1
20040157337 Burke et al. Aug 2004 A1
20040157339 Nurke et al. Aug 2004 A1
20040172284 Sullivan et al. Sep 2004 A1
20040182703 Bell et al. Sep 2004 A1
20040197935 Forrow et al. Oct 2004 A1
20040199409 Brown Oct 2004 A1
20040217019 Cai et al. Nov 2004 A1
20040219694 Chittock et al. Nov 2004 A1
20040223877 Kim et al. Nov 2004 A1
20040259180 Burke et al. Dec 2004 A1
20050009126 Andrews et al. Jan 2005 A1
20050019848 Lee et al. Jan 2005 A1
20050033603 Suzuki et al. Feb 2005 A1
20050038332 Saidara et al. Feb 2005 A1
20050045476 Neel et al. Mar 2005 A1
20050049179 Davidson et al. Mar 2005 A1
20050056539 Morgan et al. Mar 2005 A1
20050059895 Brown Mar 2005 A1
20050065760 Murtfeldt et al. Mar 2005 A1
20050067277 Pierce et al. Mar 2005 A1
20050074368 Moller et al. Apr 2005 A1
20050080652 Brown Apr 2005 A1
20050086083 Brown Apr 2005 A1
20050109618 Davies May 2005 A1
20050116820 Goldreich Jun 2005 A1
20050133368 Davies et al. Jun 2005 A1
20050137530 Campbell et al. Jun 2005 A1
20050139469 Davies et al. Jun 2005 A1
20050143675 Neel et al. Jun 2005 A1
20050143864 Blomquist Jun 2005 A1
20050161344 Kermani et al. Jul 2005 A1
20050163657 Childers et al. Jul 2005 A1
20050176153 Ohara et al. Aug 2005 A1
20050183965 Davies et al. Aug 2005 A1
20050187442 Cho et al. Aug 2005 A1
20050192492 Cho et al. Sep 2005 A1
20050197553 Cooper Sep 2005 A1
20050227370 Ramel et al. Oct 2005 A1
20050239156 Drucker et al. Oct 2005 A1
20050240119 Draudt et al. Oct 2005 A1
20050240444 Wooten et al. Oct 2005 A1
20050245904 Estes et al. Nov 2005 A1
20050256739 Brown Nov 2005 A1
20050260769 Jonsson et al. Nov 2005 A1
20050287499 Yeager Dec 2005 A1
20060004611 Brown Jan 2006 A1
20060009705 Brown Jan 2006 A1
20060009706 Brown Jan 2006 A1
20060010014 Brown Jan 2006 A1
20060030759 Weiner et al. Feb 2006 A1
20060064035 Wang et al. Mar 2006 A1
20060080152 Brown Apr 2006 A1
20060100910 Brown May 2006 A1
20060132292 Blomquist Jun 2006 A1
20060144704 Ghesquiere et al. Jul 2006 A1
20060178914 Brown Aug 2006 A1
20060191787 Wang et al. Aug 2006 A1
20060201805 Forrow et al. Sep 2006 A1
20060229502 Pollock et al. Oct 2006 A1
20060231421 Diamond et al. Oct 2006 A1
20060231423 Harding et al. Oct 2006 A1
20060247951 Brown Nov 2006 A1
20060260940 McAleer et al. Nov 2006 A1
20060279431 Bakarania et al. Dec 2006 A1
20060286620 Werner et al. Dec 2006 A1
20070028186 Park Feb 2007 A1
20070048878 Carroll et al. Mar 2007 A1
20070061167 Brown Mar 2007 A1
20070065342 Brown et al. Mar 2007 A1
20070087397 Kraft et al. Apr 2007 A1
20070088269 Valego Apr 2007 A1
20070094049 Brown Apr 2007 A1
20070100665 Brown May 2007 A1
20070118403 Brown May 2007 A1
20070118404 Brown May 2007 A1
20070118588 Brown May 2007 A1
20070118589 Brown May 2007 A1
20070167693 Scholler et al. Jul 2007 A1
20070170054 Wilsey Jul 2007 A2
20070170055 Wilsey Jul 2007 A2
20070179352 Randlov et al. Aug 2007 A1
20070188349 Staniszewski Aug 2007 A1
20070200734 Lee et al. Aug 2007 A1
20070213603 Brown Sep 2007 A1
20070213604 Brown Sep 2007 A1
20070213605 Brown Sep 2007 A1
20070213608 Brown Sep 2007 A1
20070218543 Flaherty et al. Sep 2007 A1
20070230155 Christol et al. Oct 2007 A1
20070231209 Cosentino et al. Oct 2007 A1
20070231846 Cosentino et al. Oct 2007 A1
20070255114 Ackermann et al. Nov 2007 A1
20070255123 Cummings et al. Nov 2007 A1
20070255126 Moberg et al. Nov 2007 A1
20070266871 Wegner et al. Nov 2007 A1
20070276209 Emoto et al. Nov 2007 A1
20070276621 Davies et al. Nov 2007 A1
20070281321 Nagale et al. Dec 2007 A1
20070287895 Brown Dec 2007 A1
20070287985 Estes et al. Dec 2007 A1
20070289881 Forrow et al. Dec 2007 A1
20070299321 Brown Dec 2007 A1
20080011059 Davies et al. Jan 2008 A1
20080023326 Forrow et al. Jan 2008 A1
20080026473 Wang et al. Jan 2008 A1
20080032407 Brown Feb 2008 A1
20080035478 Wegner et al. Feb 2008 A1
20080073207 Teodorczyk et al. Mar 2008 A1
20080075143 Lampke-Honeyghan et al. Mar 2008 A1
20080103447 Reggiardo et al. May 2008 A1
20080106431 Blomquist May 2008 A1
20080114228 McCluskey et al. May 2008 A1
20080118401 Kirchhevel et al. May 2008 A1
20080119702 Reggiardo May 2008 A1
20080119710 Reggiardo et al. May 2008 A1
20080133059 Trippel et al. Jun 2008 A1
20080171967 Blomquist et al. Jul 2008 A1
20080172026 Blomquist Jul 2008 A1
20080172027 Blomquist Jul 2008 A1
20080172028 Blomquist Jul 2008 A1
20080172029 Blomquist Jul 2008 A1
20080172030 Blomquist Jul 2008 A1
20080172031 Blomquist Jul 2008 A1
20080177149 Weinert et al. Jul 2008 A1
20080177822 Yoneda Jul 2008 A1
20080194934 Ray et al. Aug 2008 A1
20080257020 Jung Oct 2008 A1
20080294024 Cosentino et al. Nov 2008 A1
20080318624 Hedtke et al. Dec 2008 A1
20090051823 Tsurumoto et al. Feb 2009 A1
20090062664 Chang et al. Mar 2009 A1
20090156923 Power et al. Jun 2009 A1
20090171482 Mindeman et al. Jul 2009 A1
20090187351 Orr et al. Jul 2009 A1
20090227855 Hill et al. Sep 2009 A1
20090240127 Ray Sep 2009 A1
20090257020 Paolino Oct 2009 A1
20090326355 Brenneman et al. Dec 2009 A1
20100033138 Alger et al. Feb 2010 A1
20100041084 Stephens et al. Feb 2010 A1
20100069730 Bergstrom et al. Mar 2010 A1
20110263959 Young et al. Oct 2011 A1
20120189497 Jung et al. Jul 2012 A1
Foreign Referenced Citations (32)
Number Date Country
1472536 Feb 2004 CN
1871576 Nov 2006 CN
1917580 Feb 2007 CN
101002092 Jul 2007 CN
101022762 Aug 2007 CN
101137320 Mar 2008 CN
101238466 Aug 2008 CN
4315532 Nov 1993 DE
0777123 Jun 1997 EP
1369688 Dec 2003 EP
1413245 Apr 2004 EP
1144028 Jun 2004 EP
1563786 Aug 2005 EP
1733677 Dec 2006 EP
1733678 Dec 2006 EP
2103251 Sep 2009 EP
2159625 Dec 1985 GB
2005237484 Sep 2005 JP
2008501426 Jan 2008 JP
2010504729 Feb 2010 JP
200530584 Sep 2005 TW
WO 9411831 May 1994 WO
9524233 Sep 1995 WO
WO 0224065 Mar 2002 WO
WO 2004056264 Jul 2004 WO
WO 2005106446 Nov 2005 WO
WO 2005121785 Dec 2005 WO
2006034104 Mar 2006 WO
2006037802 Apr 2006 WO
WO 2006072035 Jul 2006 WO
WO 2007019289 Feb 2007 WO
WO 2007019384 Feb 2007 WO
Non-Patent Literature Citations (13)
Entry
English translation of First Search Report issued in corresponding Chinese Patent Application No. 200910134640.0, dated Jan. 5, 2013, 3 pages.
Patent Examination Report No. 1 issued in corresponding Australian Patent application No. 2009201094, dated Jun. 14, 2013, 3 pages.
English translation of Second Office Action issued in corresponding Chinese Patent Application No. 200910134640.0, dated Aug. 22, 2013, 17 pages.
English translation of Fourth Office Action issued in corresponding Chinese Patent Application No. 200910134640.0, dated Jun. 5, 2014, 23 pages.
Chinese Patent Application No. 200910134640.0, Chinese First Office Action dated Jan. 10, 2013, 16 pages, State Intellectual Property Office, P.R. China.
Japanese Patent Application No. 2009-067317, Japanese Notification of Reasons for Refusal dated Jul. 16, 2013, 2 pages.
China Patent Application No. 200910134640.0, Third Office Action, 18 pages, Jan. 23, 2014.
Japanese Patent Application No. 2009-067317, Notification of Reason for Refusal, 3 pages, Dec. 3, 2013.
European Search Report, Netherlands, Jul. 31, 2009, re Application 09250775.5.
Taiwan Office Action issued in Taiwan Patent Application No. 98109011, dated Apr. 3, 2014, 9 pages.
European Examination Report issued in related European Patent Application No. 09250775.5, dated Nov. 20, 2014, 8 pages.
Notice of Preliminary Rejection issued in related Korean Patent Application No. 10-2009-0024068, dated Nov. 26, 2014, 15 pages.
Notice of Final Rejection issued in related Korean Patent Application No. 10-2009-0024068, dated Mar. 20, 2015, 6 pages.
Related Publications (1)
Number Date Country
20150082227 A1 Mar 2015 US
Provisional Applications (1)
Number Date Country
61038624 Mar 2008 US
Divisions (1)
Number Date Country
Parent 12408613 Mar 2009 US
Child 14549667 US